Adams Asset Advisors, LLC - CALUMET SPECIALTY PRODS PTNR ownership

CALUMET SPECIALTY PRODS PTNR's ticker is CLMT and the CUSIP is 131476103. A total of 66 filers reported holding CALUMET SPECIALTY PRODS PTNR in Q4 2018. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Adams Asset Advisors, LLC ownership history of CALUMET SPECIALTY PRODS PTNR
ValueSharesWeighting
Q3 2023$103,934,808
+20.4%
5,441,6130.0%13.94%
+10.7%
Q2 2023$86,303,982
-8.7%
5,441,6130.0%12.60%
-0.5%
Q1 2023$94,575,234
+3.0%
5,441,6130.0%12.66%
+2.8%
Q4 2022$91,854,427
+31.8%
5,441,613
+0.0%
12.32%
+14.0%
Q3 2022$69,700,000
+23.5%
5,441,094
+0.2%
10.81%
+26.4%
Q2 2022$56,429,000
-20.6%
5,431,094
+4.0%
8.55%
-18.2%
Q1 2022$71,108,000
+3.2%
5,224,715
+0.1%
10.45%
-16.7%
Q4 2021$68,930,000
+69.2%
5,222,003
+1.4%
12.55%
+53.0%
Q3 2021$40,730,000
+28.5%
5,149,218
+11.6%
8.20%
+32.1%
Q2 2021$31,706,000
+14.1%
4,615,224
+1.3%
6.21%
+3.7%
Q1 2021$27,786,000
+94.9%
4,555,2240.0%5.99%
+53.7%
Q4 2020$14,257,000
+26.2%
4,555,224
+2.8%
3.90%
+8.7%
Q3 2020$11,295,000
+13.9%
4,429,674
+1.9%
3.58%
+22.0%
Q2 2020$9,913,000
+117.8%
4,348,014
+0.3%
2.94%
+61.3%
Q1 2020$4,551,000
-70.2%
4,334,514
+3.7%
1.82%
-31.3%
Q4 2019$15,252,000
+13.2%
4,178,667
+12.9%
2.65%
+20.9%
Q3 2019$13,474,000
-8.8%
3,701,864
+5.0%
2.19%
-3.8%
Q2 2019$14,774,000
+17.7%
3,526,123
-0.0%
2.28%
+36.3%
Q1 2019$12,556,000
+78.8%
3,527,128
+11.0%
1.67%
+68.8%
Q4 2018$7,023,000
+33.1%
3,178,028
+91.3%
0.99%
+73.6%
Q3 2018$5,276,000
-16.7%
1,660,8800.0%0.57%
-16.4%
Q2 2018$6,337,000
+3.3%
1,660,8800.0%0.68%
-18.2%
Q1 2018$6,136,000
-49.4%
1,660,880
+18.6%
0.84%
-44.0%
Q4 2017$12,117,000
+77.4%
1,399,880
+71.1%
1.49%
+60.2%
Q3 2017$6,830,000
+127.8%
817,980
+16.0%
0.93%
+111.1%
Q2 2017$2,998,000
+25.1%
705,332
+11.9%
0.44%
+29.3%
Q1 2017$2,396,000
+46.3%
630,600
+54.0%
0.34%
+57.9%
Q4 2016$1,638,000
-11.3%
409,5000.0%0.22%
-16.0%
Q3 2016$1,846,000
-8.0%
409,5000.0%0.26%
-25.1%
Q2 2016$2,006,000
-76.2%
409,500
-43.0%
0.34%
-78.4%
Q1 2016$8,436,000
-41.2%
718,010
-0.4%
1.59%
-41.7%
Q4 2015$14,352,000
-19.0%
720,860
-1.2%
2.72%
-18.1%
Q3 2015$17,722,000
-7.3%
729,934
-2.8%
3.33%
-6.4%
Q2 2015$19,125,000
+12.9%
751,181
+6.6%
3.55%
+11.0%
Q1 2015$16,940,000
+9.4%
704,396
+2.0%
3.20%
+16.5%
Q4 2014$15,479,000
-13.3%
690,730
+6.2%
2.75%
-8.5%
Q3 2014$17,846,000
-12.1%
650,161
+1.8%
3.00%
-15.4%
Q2 2014$20,314,000
+22.4%
638,820
-0.5%
3.55%
+23.3%
Q1 2014$16,595,000
+2.5%
642,260
+3.3%
2.88%
+4.9%
Q4 2013$16,183,000
+11.2%
621,955
+16.6%
2.74%
+7.8%
Q3 2013$14,551,000
-18.1%
533,207
+9.1%
2.55%
-7.8%
Q2 2013$17,773,000488,5572.76%
Other shareholders
CALUMET SPECIALTY PRODS PTNR shareholders Q4 2018
NameSharesValueWeighting ↓
Evermore Global Advisors, LLC 2,249,209$7,040,0007.61%
Adams Asset Advisors, LLC 4,555,224$14,257,0003.90%
KNOTT DAVID M 2,645,000$8,279,0003.75%
Springhouse Capital Management, LP 356,722$1,117,0001.08%
Barnett & Company, Inc. 309,882$969,0000.61%
Windsor Wealth Management, Inc. 206,176$645,0000.16%
Danda Trouve Investment Management, Inc. 17,738$56,0000.07%
O'Brien Greene & Co. Inc 33,001$103,0000.04%
Plancorp, LLC 45,000$141,0000.04%
Accel Wealth Management 10,306$32,0000.03%
View complete list of CALUMET SPECIALTY PRODS PTNR shareholders